• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Lyra Therapeutics Inc (NQ: LYRA )

    4.630 -0.620 (-11.81%)
    Streaming Delayed Price Updated: 4:00 PM EDT, May 2, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 582,604
    Open 5.260
    Bid (Size) 4.700 (5)
    Ask (Size) 4.800 (1)
    Prev. Close 5.250
    Today's Range 4.580 - 5.260
    52wk Range 2.500 - 6.790
    Shares Outstanding 31,836,815
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    LYRA Stock Earnings: Lyra Therapeutics Misses EPS, Beats Revenue for Q1 2024
    LYRA stock results show that Lyra Therapeutics missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
    Via InvestorPlace
    LYRA Stock Earnings: Lyra Therapeutics Beats EPS, Misses Revenue for Q4 2023
    LYRA stock results show that Lyra Therapeutics beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023. 
    Via InvestorPlace

    Performance

    YTD
    -10.96%
    -10.96%
    1 Month
    -25.92%
    -25.92%
    3 Month
    +1.76%
    +1.76%
    6 Month
    +56.95%
    +56.95%
    1 Year
    +69.60%
    +69.60%

    More News

    Read More
    What 4 Analyst Ratings Have To Say About Lyra Therapeutics
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For August 31, 2023
    Via Benzinga
    Lyra Therapeutics: Q1 Earnings Insights
    Via Benzinga
    Lyra Therapeutics's Return On Capital Employed Insights
    Via Benzinga
    Why Surgalign Holdings Shares Are Trading Lower By Around 75%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Stocks That Hit 52-Week Lows On Monday
    Via Benzinga
    Stocks That Hit 52-Week Lows On Thursday
    Via Benzinga
    Important Biotech Catalysts For September 13, 2022 - End Of The Day Summary
    Via Benzinga
    Lyra Therapeutics: Q2 Earnings Insights
    Via Benzinga
    Peak Sales Potential For This ENT-Focused Stock Is Under-Appreciated, Says Cantor
    Via Benzinga
    Recap: Lyra Therapeutics Q1 Earnings
    Via Benzinga
    Stocks That Hit 52-Week Lows On Wednesday
    Via Benzinga
    Lyra's Mid-Stage Chronic Rhinosinusitis Candidate Study Progressed, Shares Fall
    Via Benzinga
    Important Biotech Catalysts For September 8, 2022 - End Of The Day Summary
    Via Benzinga
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    Lyra Therapeutics's Return On Capital Employed Insights
    Via Benzinga
    7 Stocks to Watch for Major Insider Trading Clues
    Via InvestorPlace
    Benzinga's Top Ratings Upgrades, Downgrades For May 24, 2022
    Via Benzinga
    The Week Ahead In Biotech (April 24-April 30): Bristol-Myers Squibb, Supernus, Hutchmed, Axsome, Coherus FDA Decisions, Big Pharma Earnings, IPOs And More
    Via Benzinga
    90 Biggest Movers From Yesterday
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.